The pharmaceutical industry relies heavily on a robust supply of chemical intermediates to drive innovation and production. Among these, compounds related to established drugs often hold significant value for research and development. One such compound is 1-(4-Methoxyphenyl)-2-aminoethyl cyclohexanol hydrochloride, identified by CAS 93413-77-5. This molecule is recognized as a key intermediate in the synthesis of Venlafaxine, a widely prescribed antidepressant, and also functions as one of its important metabolites, Dinorvenlafaxine.

For pharmaceutical scientists, understanding the chemical properties and synthetic utility of CAS 93413-77-5 is crucial. Its structure facilitates the creation of complex molecular architectures required for modern pharmaceuticals, particularly those designed to modulate neurotransmitter activity in the brain. This makes it an invaluable tool for companies engaged in developing treatments for depression, anxiety disorders, and other central nervous system conditions. The ability to reliably buy this intermediate allows for consistent progress in drug formulation and testing.

Procuring pharmaceutical intermediates requires a meticulous approach to supplier selection. When looking to purchase 1-(4-Methoxyphenyl)-2-aminoethyl cyclohexanol hydrochloride, researchers and procurement specialists often prioritize suppliers who can guarantee high purity levels (e.g., 99% by HPLC) and consistent batch-to-batch quality. Manufacturers based in China are often sought after due to their competitive pricing and established export capabilities. It's essential to obtain detailed technical specifications and safety data from your chosen supplier to ensure compliance and efficacy.

The broader context of Venlafaxine intermediates highlights the intricate nature of pharmaceutical manufacturing. Beyond synthesis, these compounds are vital for pharmacokinetic studies, impurity profiling, and creating reference standards. As the demand for effective psychiatric medications continues, the role of intermediates like 1-(4-Methoxyphenyl)-2-aminoethyl cyclohexanol hydrochloride remains critical. Securing a dependable source for this compound is a strategic advantage for companies in the pharmaceutical sector.

When engaging with potential suppliers, inquiring about lead times, packaging options, and regulatory support is advisable. Many manufacturers offer various packaging sizes suitable for both laboratory-scale research and larger commercial production needs. For organizations needing to buy this compound, a proactive approach to supplier vetting and relationship building will ensure a smooth and efficient procurement process, contributing to successful drug development timelines.

In summary, 1-(4-Methoxyphenyl)-2-aminoethyl cyclohexanol hydrochloride (CAS 93413-77-5) stands out as a critical pharmaceutical intermediate with significant implications for the development of CNS therapies. Its dual role as a synthetic precursor and a metabolite underscores its importance in pharmaceutical R&D. Partnering with a reliable manufacturer ensures access to this essential chemical, supporting the continuous innovation within the pharmaceutical landscape.